XEROGEL NASAL/EPISTAXIS 2 PACK: payments to doctors
Payments that named XEROGEL NASAL/EPISTAXIS 2 PACK as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $62K
- Providers
- 170
- Transactions
- 260
- Average per transaction
- $238
The per-transaction average — $238 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 170 providers the average total is $364, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Stryker | $61,944 | 100.0% |